Oric Pharmaceuticals (ORIC) Competitors $10.57 -0.03 (-0.28%) As of 01:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ORIC vs. AAPG, PTCT, ACLX, AKRO, LNTH, MIRM, MTSR, ZLAB, PTGX, and MLTXShould you be buying Oric Pharmaceuticals stock or one of its competitors? The main competitors of Oric Pharmaceuticals include Ascentage Pharma Group International (AAPG), PTC Therapeutics (PTCT), Arcellx (ACLX), Akero Therapeutics (AKRO), Lantheus (LNTH), Mirum Pharmaceuticals (MIRM), Metsera (MTSR), Zai Lab (ZLAB), Protagonist Therapeutics (PTGX), and MoonLake Immunotherapeutics (MLTX). These companies are all part of the "pharmaceutical products" industry. Oric Pharmaceuticals vs. Its Competitors Ascentage Pharma Group International PTC Therapeutics Arcellx Akero Therapeutics Lantheus Mirum Pharmaceuticals Metsera Zai Lab Protagonist Therapeutics MoonLake Immunotherapeutics Ascentage Pharma Group International (NASDAQ:AAPG) and Oric Pharmaceuticals (NASDAQ:ORIC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment. Do institutionals and insiders believe in AAPG or ORIC? 95.1% of Oric Pharmaceuticals shares are owned by institutional investors. 6.8% of Oric Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is AAPG or ORIC more profitable? Ascentage Pharma Group International's return on equity of 0.00% beat Oric Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Ascentage Pharma Group InternationalN/A N/A N/A Oric Pharmaceuticals N/A -51.75%-47.09% Which has better earnings & valuation, AAPG or ORIC? Ascentage Pharma Group International has higher revenue and earnings than Oric Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscentage Pharma Group International$390.60M9.24-$55.54MN/AN/AOric PharmaceuticalsN/AN/A-$127.85M-$1.89-5.59 Do analysts prefer AAPG or ORIC? Oric Pharmaceuticals has a consensus price target of $17.63, indicating a potential upside of 66.75%. Given Oric Pharmaceuticals' higher probable upside, analysts clearly believe Oric Pharmaceuticals is more favorable than Ascentage Pharma Group International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascentage Pharma Group International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Oric Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90 Does the media prefer AAPG or ORIC? In the previous week, Oric Pharmaceuticals had 5 more articles in the media than Ascentage Pharma Group International. MarketBeat recorded 7 mentions for Oric Pharmaceuticals and 2 mentions for Ascentage Pharma Group International. Oric Pharmaceuticals' average media sentiment score of 1.12 beat Ascentage Pharma Group International's score of 1.08 indicating that Oric Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascentage Pharma Group International 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Oric Pharmaceuticals 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOric Pharmaceuticals beats Ascentage Pharma Group International on 6 of the 11 factors compared between the two stocks. Get Oric Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ORIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ORIC vs. The Competition Export to ExcelMetricOric PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.02B$3.09B$5.75B$9.85BDividend YieldN/A2.28%6.66%4.49%P/E Ratio-5.5820.8882.7926.52Price / SalesN/A369.93499.49162.43Price / CashN/A43.5325.7028.92Price / Book3.168.0310.786.50Net Income-$127.85M-$53.35M$3.28B$266.34M7 Day Performance5.38%-1.05%-0.42%-1.25%1 Month Performance8.52%5.84%6.47%3.30%1 Year Performance10.22%10.76%49.47%23.59% Oric Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ORICOric Pharmaceuticals4.7012 of 5 stars$10.57-0.3%$17.63+66.7%+5.3%$1.02BN/A-5.5880News CoveragePositive NewsAnalyst ForecastAAPGAscentage Pharma Group InternationalN/A$42.47+3.3%N/AN/A$3.95B$134.35M0.00600Gap DownPTCTPTC Therapeutics3.9344 of 5 stars$49.33-0.9%$69.15+40.2%+66.3%$3.92B$806.78M7.081,410News CoverageAnalyst ForecastACLXArcellx2.2095 of 5 stars$69.39-1.2%$114.31+64.7%+7.7%$3.85B$107.94M-20.2980News CoveragePositive NewsAKROAkero Therapeutics3.9112 of 5 stars$46.73-0.4%$81.57+74.6%+75.5%$3.74BN/A-23.3730News CoveragePositive NewsAnalyst ForecastLNTHLantheus4.8897 of 5 stars$54.90-1.1%$105.50+92.2%-47.7%$3.73B$1.53B14.60700Positive NewsShort Interest ↓MIRMMirum Pharmaceuticals3.2804 of 5 stars$73.87-2.2%$74.13+0.3%+80.6%$3.71B$336.89M-61.05140Positive NewsMTSRMetseraN/A$35.29+0.7%$59.00+67.2%N/A$3.71BN/A0.0081News CoverageAnalyst ForecastZLABZai Lab2.5569 of 5 stars$33.10+2.7%$56.35+70.2%+61.8%$3.70B$398.99M-16.231,869News CoveragePTGXProtagonist Therapeutics1.7482 of 5 stars$59.05+1.6%$67.20+13.8%+40.3%$3.67B$434.43M84.36120News CoveragePositive NewsMLTXMoonLake Immunotherapeutics2.4637 of 5 stars$55.75+1.7%$74.43+33.5%+28.5%$3.58BN/A-20.052News CoveragePositive NewsAnalyst Revision Related Companies and Tools Related Companies Ascentage Pharma Group International Competitors PTC Therapeutics Competitors Arcellx Competitors Akero Therapeutics Competitors Lantheus Competitors Mirum Pharmaceuticals Competitors Metsera Competitors Zai Lab Competitors Protagonist Therapeutics Competitors MoonLake Immunotherapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ORIC) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oric Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oric Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ORIC Stock Alerts